Literature DB >> 17045972

Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation.

Fei Xu1, Mark R Plummer, Guo-Wei Len, Takanobu Nakazawa, Tadashi Yamamoto, Ira B Black, Kuo Wu.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a potent modulator of hippocampal synaptic plasticity. Previously, we found that one of the targets of BDNF modulation is NR2B-containing NMDA receptors. Furthermore, exposure to the trophin rapidly increases NMDA receptor activity and enhances tyrosine phosphorylation of NR2B in cortical and hippocampal postsynaptic densities (PSDs), potentially linking receptor phosphorylation to synaptic plasticity. To define the specific NR2B residue(s) regulated by BDNF, we focused on tyrosine 1472, phosphorylation of which increases after LTP. BDNF rapidly increased phosphorylation in cortical PSDs. The tyrosine kinase Fyn is critical since BDNF-dependent phosphorylation was abolished in Fyn knockout mice. Single-channel patch clamp recordings showed that Fyn is required for the increase in NMDA receptor activity elicited by BDNF. Collectively, our results suggest that BDNF enhances phosphorylation of NR2B tyrosine 1472 through activation of Fyn, leading to alteration of NMDA receptor activity and increased synaptic transmission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045972     DOI: 10.1016/j.brainres.2006.08.129

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  Postsynaptic BDNF signalling regulates long-term potentiation at thalamo-amygdala afferents.

Authors:  S Meis; T Endres; V Lessmann
Journal:  J Physiol       Date:  2011-11-14       Impact factor: 5.182

Review 2.  Progesterone and neuroprotection.

Authors:  Meharvan Singh; Chang Su
Journal:  Horm Behav       Date:  2012-06-23       Impact factor: 3.587

3.  Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.

Authors:  L V Kristiansen; B Bakir; V Haroutunian; J H Meador-Woodruff
Journal:  Schizophr Res       Date:  2010-03-29       Impact factor: 4.939

4.  Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels.

Authors:  Jian Xu; Pradeep Kurup; Garikoitz Azkona; Tyler D Baguley; Ana Saavedra; Angus C Nairn; Jonathan A Ellman; Esther Pérez-Navarro; Paul J Lombroso
Journal:  J Neurochem       Date:  2015-09-17       Impact factor: 5.372

Review 5.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  Infralimbic BDNF/TrkB enhancement of GluN2B currents facilitates extinction of a cocaine-conditioned place preference.

Authors:  James M Otis; Michael K Fitzgerald; Devin Mueller
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

7.  Alteration of the Centromedial Amygdala Glutamatergic Synapses by the BDNF Val66Met Polymorphism.

Authors:  Christopher Galvin; Francis S Lee; Ipe Ninan
Journal:  Neuropsychopharmacology       Date:  2015-03-18       Impact factor: 7.853

8.  BDNF released during neuropathic pain potentiates NMDA receptors in primary afferent terminals.

Authors:  Wenling Chen; Wendy Walwyn; Helena S Ennes; Hyeyoung Kim; James A McRoberts; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2014-03-11       Impact factor: 3.386

Review 9.  Progesterone, brain-derived neurotrophic factor and neuroprotection.

Authors:  M Singh; C Su
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

10.  Antidepressant-like activity of zinc: further behavioral and molecular evidence.

Authors:  Magdalena Sowa-Kućma; Beata Legutko; Bernadeta Szewczyk; Kinga Novak; Paweł Znojek; Ewa Poleszak; Mariusz Papp; Andrzej Pilc; Gabriel Nowak
Journal:  J Neural Transm (Vienna)       Date:  2008-09-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.